A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Gossage, M.D., MBA
MedImmune LLC
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Calgary, Alberta, Canada
- Research Site
Vancouver, British Columbia, Canada
- Research Site
Hamilton, Ontario, Canada
- Research Site
Montreal, Quebec, Canada
- Research Site
Québec, Quebec, Canada
- Research Site
Denver, Colorado, United States
- Research Site
Pittsburgh, Pennsylvania, United States
- Research Site
Galveston, Texas, United States
- Research Site
Houston, Texas, United States
- Research Site
Houston, Texas, United States
- Research Site
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2008
- Primary completion
- 31 Jan 2011
- Completion
- 31 Mar 2011
- Last update posted
- 10 Oct 2012
- Registered enrollment
- 27
- Registry id
- NCT00659659
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.